- Revenue
- $3.9M
- Customers
- -
- Year founded
- -
- Funding
- -
- Team size
- 35
- Growth
- -
Top 16 Drug Discovery Software SaaS Companies in May 2026
As of May 2026, there are 16 SaaS companies in Drug Discovery Software. They have combined revenues of $211.2M and employ 912 people. They have raised $709.9M and serve 55.2K customers combined.
Drug Discovery Software encompasses a range of tools and applications that aid in the development of new pharmaceuticals. These solutions streamline the research process by enabling researchers to design, analyze, and optimize drug candidates more efficiently. Common use cases include target identification, lead optimization, and preclinical trials, wherein software facilitates simulations and predictions that guide decision-making during the drug discovery pipeline. Typically, drug discovery software features include molecular modeling, compound library management, virtual screening, and data analysis capabilities. Users of this software include pharmaceutical companies, biotech firms, and academic institutions focused on drug development. By automating complex processes, these tools help researchers reduce costs and timeframes associated with bringing new medicines to market.
Filters
Sorting: Highest -> Lowest
Top Drug Discovery Software Companies
Showing 10 of 7 companies ranked by annual revenue.
2
Discngine
Paris, France
Developer of life sciences research software and applications. The company's software-as-a-service, plate based assay data acquisition platform facilitates discovery of of innovative molecules, conceives high content screening experiments analyses, organizes and stores experimental results from a large variety of sources and provides primary and secondary screening of results and designs dose response screening runs, enabling pharmaceutical and cosmetics firms to manage and visualize data and speed up the decision-making processes.
- Revenue
- $3.4M
- Customers
- -
- Year founded
- 2004
- Funding
- $1.3M
- Team size
- 65
- Growth
- 101.63%
3
VeriSIM Life
San Francisco, California, United States
Developer of disease-specific simulation models designed to replace animal drug testing by using artificial intelligence. The company's models increase human life expectancy through intelligence driven biosystem simulations to truly personalize patient treatment, enabling pharmaceutical scientists to improve the accuracy and efficiency of drug development and make personalized health care a reality.
- Revenue
- $3M
- Customers
- -
- Year founded
- 2017
- Funding
- $21.7M
- Team size
- 26
- Growth
- 32.97%
4
Rosalind
San Diego, California, United States
Based in the Genomics Capital of San Diego, ROSALIND is the first-ever genomics discovery and collaboration platform specifically designed for scientists and biologists. With ROSALIND, anyone can explore and interpret multi-omic datasets, without any prior bioinformatics skills. Named in honor of pioneering researcher Rosalind Franklin, who made a major contribution to the discovery of the double-helix structure of DNA with her famous photograph 51, the ROSALIND platform aims to simplify the practice of genomic data interpretation, so that biologists, researchers and drug developers can harness the potential of genomic information while reducing costs and increasing productivity.
- Revenue
- $2.9M
- Customers
- -
- Year founded
- 2013
- Funding
- -
- Team size
- 26
- Growth
- -
5
InSilicoTrials
Stafford, England, United Kingdom
InSilicoTrials.com is a web-based platform, which provides a user-friendly computational modeling and simulation environment where many integrated easy-to-use in silico tools are readily available. The platform targets primarily users from the medical devices and pharmaceutical sectors. The in silico tools available for medical devices enable computational testing in different biomedical areas like radiology, orthopedics and cardiovascular during product design, development and validation processes. For the pharmaceutical sector, the platform provides access to in silico tools developed at all stages of the drug discovery and development processes and for many different therapeutic areas. The platform further ensures users management, content protection, simulation solvers, a validated environment, IT security, results reporting, pay-per-use licenses, the computational power of cloud machines and cloud storage.
- Revenue
- $2.7M
- Customers
- 55.2K
- Year founded
- 2016
- Funding
- -
- Team size
- 23
- Growth
- 81.67%
6
GEn1E Lifesciences
Palo Alto, California, United States
AI platform accelerating therapies for rare & inflammatory diseases.
- Revenue
- $1.8M
- Customers
- -
- Year founded
- 2018
- Funding
- -
- Team size
- 12
- Growth
- -
7
QSimulate
Boston, Massachusetts, United States
Developer of tools intended for quantum molecular simulations in the cloud. The company offers a cloud-based time-to-solution simulation platform for chemical and pharmaceutical industries, enabling companies to accelerate their computational R&D.
- Revenue
- $1.5M
- Customers
- -
- Year founded
- 2018
- Funding
- -
- Team size
- 26
- Growth
- 67.99%
Inclusion Criteria
- Offers tools for molecular modeling and simulations - Supports data analysis related to drug interactions and efficacy - Aids in target identification and validation in the drug discovery process - Includes features for library management of drug compounds - Must facilitate preclinical trial planning and analysis - Not just general research software; must specifically cater to drug discovery workflows